Biotech Startups

Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.

6 investors

QSM Diagnostics develops point-of-care veterinary diagnostics for the rapid identification of bacterial infections. The company, a spinout of the Goluch Research Group at Northeastern University, builds sensors and medical devices for the veterinary market.

6 investors

Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention. The company serves the precision healthcare and life sciences research market with biomarker detection tools.

6 investors

Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.

6 investors

Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells. The company applies synthetic biology, single-cell transcriptomic data, RNA-editing enzymes, and logic gates to create "smart" mRNA therapies for difficult-to-treat diseases.

6 investors

Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health. It works in high-throughput laboratory sciences.

6 investors

RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.

6 investors

Rejuvenation Technologies develops mRNA therapeutics designed to extend healthspan by lengthening short telomeres, with preclinical results in fibrotic liver and lung disease. The company is moving toward clinical trials via IND-enabling studies and builds on a Stanford-patented platform.

6 investors

Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques. The platform serves pharmaceutical and biotech researchers seeking to accelerate drug discovery across multiple phases of development.

6 investors

Resurrect Bio develops more durable crop disease resistance by engineering plant immune receptors, combining plant molecular immunology, computational biology, AI, and high-throughput screening. The company, spun out of The Sainsbury Laboratory in Norwich, serves the agricultural sector with crop protection against evolving plant diseases.

6 investors

Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.

6 investors

6 investors

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases. The company focuses on novel therapeutic approaches for patients with rare respiratory conditions.

6 investors

Scindo uses AI and machine learning to discover and design novel enzymes for sustainable manufacturing. The company targets cosmetics, personal care, and food product manufacturers seeking to replace conventional chemistry with bio-based alternatives that reduce energy use, waste, and fossil fuel dependence.

6 investors

6 investors

Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions. The company uses advanced engineering of natural CRISPR systems to create targeted genetic medicines.

6 investors

Seaport Therapeutics develops therapeutics and medicines. The company is led by a founder with extensive experience building biotech platforms and advancing novel drug development programs.

6 investors

Seaspire develops safe and sustainable suncare and skincare products using Xanthochrome®, a proprietary class of biomolecules inspired by oceanic compounds. The company targets consumers seeking sun protection without harmful toxins.

6 investors

Senseye provides a predictive maintenance platform that uses industrial AI and domain knowledge to help maintenance teams assess asset health, anticipate failure risk, and prioritize actions across sites. It serves industrial and manufacturing organizations looking to scale predictive maintenance without relying on manual analysis or specialist skills.

6 investors

Sequence Bio works on drug target discovery, using the Newfoundland founder effect to identify genetic signals of disease and improve the success rate of drug development.

6 investors

Sequencing.com offers free storage of personal DNA data along with tools and reports that turn genetic testing results into health-related insights for consumers. The company addresses data storage, usability, and privacy challenges created by widely available consumer genetic testing.

6 investors

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.

6 investors

Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.

6 investors

SOLASTA Bio develops bio-based crop protection products as alternatives to conventional agricultural chemicals, serving the agrifood and farming sector.

6 investors